CA
NZ
UK
AU
IND
US
Genmab A/S (NASDAQ:GMAB) furnished a Form 6-K on September 29, 2026 whose sole purpose is to place its current Articles of Association on the public record. The document, dated September 24, 2026, is attached as Exhibit 3.1, and the cover report states that it …
Charming Medical Ltd (NASDAQ:MCTA) filed a Form 6-K on September 29, 2026 attaching a notice of an extraordinary general meeting, a proxy statement and a form of proxy card. The meeting is set for October 23, 2026, with a record date of September 25, …
Nano-X Imaging Ltd. (NASDAQ:NNOX) furnished a Form 6-K reporting that its shareholders approved the proposals put to them at the company's adjourned annual general meeting, held on September 29, 2026 at Ofer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, Israel. One proposal, Proposal …
OKYO Pharma Ltd (NASDAQ:OKYO) furnished a Form 6-K on September 29, 2026, attaching a press release that lays out its participation in three ophthalmic conferences over the following two weeks. The release describes the company as a clinical-stage biopharmaceutical company developing therapies for neuropathic …
● Tectonic's TX2100 was generally safe and well tolerated in a Phase 1a trial of 48 healthy volunteers.
● TELA Bio's lenders agreed not to test the minimumRevenuecovenant for the next two quarterly measurement dates.
● Unicycive resubmitted its NDA for oxylanthanum carbonate withManufacturingdata from a new third-party drug product vendor.
Allarity Therapeutics, Inc. (NASDAQ:ALLR) filed a Form 8-K that attaches a press release dated September 28, 2026, announcing that it has expanded its in-house laboratory in Tarpon Springs, Florida to include proteomics and cell line research.
Alzamend Neuro, Inc. (NASDAQ:ALZN) furnished a Form 8-K on September 29, 2026 attaching presentation slides given the same day by the principal investigator of its Phase 1/2A clinical trial. The filing says Dr. Ovidiu C.
AngioDynamics Inc (NASDAQ:ANGO) filed two amendments to its Annual Report on Form 10-K for the fiscal year ended May 31, 2026 on September 29, 2026. Amendment No. 1, accession 0001140361-26-037943, adds the Part III information.
Please wait processing your request...